Pure Global

Insulin syringe, fixed-needle

Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Livingstone International Pty Ltd, manufactured by Anhui Tiankang Medical Technology Co Ltd in China. The device registration started on June 13, 2018.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Insulin syringe, fixed-needle
Australia TGA ARTG Registered Device
Good Name: Livingstone International Pty Ltd - Insulin syringe, fixed-needle
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Insulin syringes are made specifically for self-injections.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
June 13, 2018
Effective Date
June 13, 2018
Manufacturer
Country
China
Address
No. 228 Weiyi Road Economic Development Zone Tianchang City, Anhui Province, 239300